CMA expands probe of pharmaceutical sector
The UK’s antitrust agency last week opened three more investigations into alleged anticompetitive agreements in the pharmaceutical sector, expanding the agency’s already extensive probe of the market.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.